Speaker(s): 

Jeffrey Wojciechowski, DO, Resident, Geisinger - has nothing to disclose.

Melissa Thomas, DO, Resident, Geisinger - has nothing to disclose.

Moderator(s): 

Zachary Hoffer, MD, Staff Member, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Recognize morphology and existing prognostic factors in nasopharyngeal carcinoma.
• Review the impact of micronests in tumor stroma as a prognostic factor for patients.
• Discuss the key genomic markers of antifungal resistance in Candida auris and how WGS can be used to predict antifungal resistance.
• Evaluate the clinical and infection prevention implications of integrating WGS into hospital surveillance programs.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Zachary Hoffer, MD PhD and Jeffrey Prichard, DO have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None.